Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project

项目摘要 用于治疗大脑疾病和疾病的神经技术可以极大地改变大脑功能和行为， 监测大脑活动，收集和传输个人健康数据。产业界和学术界(IA)的合作伙伴关系发挥了作用 在将神经技术推向市场以造福公众方面发挥关键作用。然而，有重大的伦理问题 这些伙伴关系产生的问题，特别是考虑到神经技术的独特能力。如果这些 道德挑战没有得到适当的处理，科学诚信可能会受到破坏， 神经技术的设计、开发和商业化可能会受到威胁。 这个项目解决了我们目前对工业-学术界(IA)伦理复杂性的理解上的一个空白。 通过让相关的神经技术利益相关者参与(例如， 行业、研究人员、伦理学家、大学官员、患者)，以确定有希望的、实用的解决方案 解决这些伦理上的复杂性。这个项目在逻辑上跨越了三个目标，最终达到了 开发、传播和评估工具包，其中包括利益相关者知情的道德指导 负责任地引导IA神经技术合作伙伴关系。 目标1将利用与神经技术利益相关者的深入访谈来确定风险因素和伦理 IA伙伴关系面临的挑战，包括神经技术的设计、实施、报告和应用 研究。目标2将涉及德尔福共识神经技术利益相关者小组，以建立最佳 降低风险和解决内务部伙伴关系中出现的道德问题的做法和解决方案。目标 3将包括开发、传播和评估工具包，该工具包为以下各项提供指导和资源 帮助神经技术利益相关者在道德上和负责任地驾驭神经技术IA合作伙伴关系。 我们将建议为每个利益相关者群体采用具体的解决方案。 这是第一个系统地同时让不同的神经技术利益相关者参与的项目 为道德和负责任的IA神经技术伙伴关系制定实用和可操作的指导方针。我们会 开发第一个可公开访问的利益相关者信息工具包，可以适应当前和即将到来的情况 来自IA合作伙伴关系的神经技术。综上所述，这个项目将对 通过确定实际解决方案来平衡科学价值和 受托目标。

Project Summary Neurotechnologies used to treat brain disorders and diseases can drastically change brain function and behavior, monitor brain activity, and collect and transmit personal health data. Industry-academia (IA) partnerships play a critical role in bringing neurotechnologies to market for public benefit. However, there are significant ethical issues that emerge from these partnerships, especially given the unique capacities of neurotechnologies. If these ethical challenges are not handled appropriately, scientific integrity can be undermined and the objectivity in the design, development, and commercialization of neurotechnologies can be jeopardized. This project addresses a gap in our current understanding of ethical complexities in industry-academia (IA) partnerships within the neurotechnology enterprise by engaging relevant neurotechnology stakeholders (e.g., industry, researchers, ethicists, university officials, patients) to identify promising and practical solutions for addressing these ethical complexities. This project builds logically across three aims that culminate in the development, dissemination, and evaluation of a toolkit that includes stakeholder-informed guidance for ethically and responsibly navigating IA neurotechnology partnerships. Aim 1 will use in-depth interviews with neurotechnology stakeholders to identify risk factors and ethical challenges for IA partnerships, including in the design, conduct, reporting, and application of neurotechnology research. Aim 2 will involve a Delphi consensus panel of neurotechnology stakeholders to establish best practices and solutions for mitigating risk and addressing ethical issues that emerge from IA partnerships. Aim 3 will include developing, disseminating, and evaluating a toolkit that provides guidance and resources for neurotechnology stakeholders to help them ethically and responsibly navigate neurotechnology IA partnerships. We will recommend adoption of specific solutions for each stakeholder group. This is the first project to systematically and simultaneously engage diverse neurotechnology stakeholders to develop practical and actionable guidance for ethical and responsible IA neurotechnology partnerships. We will develop the first publicly accessible stakeholder-informed toolkit that can be adapted to current and forthcoming neurotechnologies resulting from IA partnerships. Taken together, this project will have considerable impact on the conduct of neurotechnology research by identifying practical solutions for balancing scientific values with fiduciary goals.